scieee AI-readable full text Open interactive document viewer

Molecularly imprinted polymers coupled to mass spectrometric detection for metallothionein sensing

Vaněčková, Tereza; Pompeiano Vaníčková, Lucie; Kuchynka, Michaela; Pomorski, Adam; Krężel, Artur; Vaculovič, Tomáš; Kanický, Viktor; Vaculovičová, Markéta; Adam, Vojtěch

Abstract

We report a facile method for detection of metallothionein (MT), a promising clinically relevant biomarker, in spiked plasma samples. This method, for the first time, integrates molecularly imprinted polymers as purification/pretreatment step with matrix assisted laser desorption/ionization time-of-flight mass spectrometric detection and with laser ablation inductively coupled plasma mass spectrometry for analysis of MTs. The prepared MT-imprinted polydopamine layer showed high binding capacity and specific recognition properties toward the template. Optimal monomer (dopamine) concentration was found to be 16 mM of dopamine. This experimental setup allows to measure mu M concentrations of MT that are present in blood as this can be used for clinical studies recognizing MT as marker of various diseases including tumour one. Presented approach not only provides fast sample throughput but also avoids the limitations of methods based on use of antibodies (e.g. high price, cross reactivity, limited availability in some cases, etc.).

Full text

Molecularly imprinted polymers coupled to mass spectrometric detection for metallothionein sensing VANĚČKOVÁ, T.; POMPEIANO VANÍČKOVÁ, L.; TVRDOŇOVÁ, M.; POMORSKI, A.; KRĘŻEL, A.; VACULOVIČ, T.; KANICKÝ, V.; VACULOVIČOVÁ, M.; ADAM, V. Talanta 2019, vol. 198, June 2019, pp. 224-229 ISSN: 0039-9140 DOI: https://doi.org/10.1016/j.talanta.2019.01.089 Accepted manuscript © 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license (http://creativecommons.org/licenses/by-nc-nd/4.0/), doi: https://doi.org/ 10.1016/j.talanta.2019.01.089 Final version available from https://www.sciencedirect.com/science/article/pii/S0039914019301109 dspace.vutbr.cz 1 Molecularly imprinted polymers coupled to mass spectrometric detection for metallothionein sensing Tereza Vaneckova1,2, Lucie Pompeiano Vanickova1,2, Michaela Tvrdonova3, Adam Pomorski4, Artur Krężel4, Tomas Vaculovic3,5, Viktor Kanicky3,5, Marketa Vaculovicova1,2, Vojtech Adam1,2* 1Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ613 00 Brno, Czech Republic 2Central European Institute of Technology, Brno University of Technology, Purkynova 123, CZ-612 00 Brno, Czech Republic 3 Department of Chemistry, Faculty of Science, Masaryk University, Kamenice 753/5, CZ-625 00 Brno, Czech Republic 4Department of Chemical Biology, Faculty of Biotechnology, University of Wroclaw, JoliotCurie 14a, 50-383 Wrocław, Poland 5 Central European Institute of Technology, Masaryk University, Kamenice 753/5, CZ-625 00 Brno, Czech Republic * Corresponding author: Vojtech Adam, Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic; E-mail: [email protected]; phone: +420-5-4513-3350; fax: +420-5-4521-2044 2 Abstract We report a facile method for detection of metallothionein (MT), a promising clinically relevant biomarker, in spiked plasma samples. This method, for the first time, integrates molecularly imprinted polymers as purification/pretreatment step with matrix assisted plasma desorption/ionization time-of-flight mass spectrometric detection and with laser ablation inductively coupled plasma mass spectrometry for analysis of MTs. The prepared MTimprinted polydopamine layer showed high binding capacity and specific recognition properties toward the template. Optimal monomer (dopamine) concentration was found to be 16 mM of dopamine. This experimental setup allows to measure µM concentrations of MT that are present in blood as this can be used for clinical studies recognizing MT as marker of various diseases including tumour one. Presented approach not only provides fast sample throughput but also avoids the limitations of methods based on use of antibodies (e.g. high price, cross-reactivity, limited availability in some cases, etc.). Keywords Metallothionein; molecularly imprinted polymers; polydopamine; MALDI-TOF-MS; LAICP-MS 3 Introduction Metallothioneins (MTs) are low molecular mass (< 7kDa), cysteine-rich proteins, ubiquitously present in practically all eukaryotes [1-3]. MTs perform a wide range of functions in an organism including essential metal homeostasis, i.e. Zn2+ and Cu+, heavy metal detoxification, i.e. Cd2+, scavenging of reactive oxygen species and regulation of transcription [4-8]. The elevated concentration of MTs has been observed in blood and/or tissues coming from patients with various tumour diseases (e.g., colon, breast, liver, kidney, lung, nasopharynx, ovary, salivary gland, prostate, thyroid, and urinary bladder cancer) as it was reviewed [9, 10], demonstrating that MTs are promising oncosuppressors [11-13]. Numerous analytical approaches have been suggested for detection and determination of MTs as reviewed elsewhere [14, 15]. More recently, a method based on the enzyme-linked immunosorbent assay and the real time polymerase chain reaction was used [16]. Another study reported a microfluidic MT electrochemical immunosensor utilizing superparamagnetic agarose beads [17], where a curve fitting approach was be used for voltammograms of various isoforms of MTs [18]. Mass spectrometry coupled with matrix assisted laser desorption/ionization (MALDI) or inductively coupled plasma (ICP) ionization was also used for determination of MTs [19]. Recently, bottom-up mass spectrometry-based approach for human MT isoforms quantification has been developed [20], nevertheless combinations of these types of detection with biological molecule recognition elements are needed. Molecularly imprinted polymers (MIPs) are biorecognition surfaces with high affinity towards desired template. Named as natural receptor mimics, MIPs are being considered as an alternative to biological receptors, such as enzymes, antibodies or aptamers [21, 22]. Their major advantages cover predictable specific recognition, low cost, ease of preparation, good mechanical/chemical stability, and reusability [23]. Although MIPs have been successfully applied using wide range of small molecules [24], imprinting of biomacromolecules, such as 4 proteins, faces challenges. Macromolecular templates have a tendency to adsorb to polymers, where it is not trivial to remove them from the polymer matrix, as they produce heterogeneous sites, and may be sensitive to denaturation or presence of organic solvents, which are usually essential for formation of polymers [22, 25]. To date, only few studies reported combination of molecular imprinting technology together with MALDI time-of-flight mass spectrometry (MALDI-TOF-MS) [26-33]. However, determination of MT using molecularly imprinting technology combined with mass spectrometric detection (neither MALDI nor ICP) has not been reported yet. In the present study, we developed an easy method for MT purification from a complex matrix using MT-selective PDA layer combined followed with MALDI-TOF-MS and LAICP-MS detection techniques (Fig. 1). The analytical performance of the sensor was evaluated. The obtained results reveal a new perspective in recognition and separation of this template, which is a potential marker of diseases. Material and methods Materials Dopamine hydrochloride, albumin from human serum (≥ 97%), Trizma® (TRIS base), and lysozyme from chicken egg white were purchased from Sigma-Aldrich company (St. Louis, MO, USA). Acetic acid (99.8%) and hydrochloric acid (reagent grade, 35%) was obtained from PENTA (Chrudim, Czech Republic). Amicon® Ultra 0.5 mL 50K Centrifugal Filters were purchased from Merck Millipore (Billerica, MA, USA). Tris-HCl buffer (20 mM, pH 8.5) was prepared from Trizma® and hydrochloric acid was used for pH adjustment. Aqueous solution of acetic acid (3%, v/v) was used as a washing buffer. Deionized water used during the experiments was prepared with a Milli-Q water purification system (Millipore, Milford, MA, USA). 5 Preparation of MT-imprinted polydopamine layer Polydopamine (PDA) MIP was prepared by self-polymerization inspired by works of [34, 35]. In brief, dopamine was dissolved in 1 mL Tris-HCl buffer (20 mM, pH 8.5). Template molecules of MT-1, MT-3 or lysozyme, for initial optimization, were then mixed with the stock solution of DA at 1:1 (v/v) ratio. The target concentration was varied depending on the experiment. Next, 1 µL of the polymerization mixture was applied on the MALDI target plate (Bruker MTP AnchorChip 384BCTM) or, in case of initial experiments, bottom of the 96 wellplate and let to polymerize and dry at the room temperature for 24 h. Subsequently, the prepared polymeric layer was overlaid with a sample solution and the incubation was carried for 1 hour at room temperature. The resulting self-assembled polymer was then washed with 3% acetic acid to remove the bound MT or lysozyme. Final wash was performed with Milli-Q water. Control, non-imprinted polymer (NIP), was prepared under the same conditions without adding the template (MT/lysozyme). Each of the analysed polymers was prepared in triplicate. Sample preparation Standard solutions The coding sequences of human metallothionein-1 (MT-1) (UniProt:P13640-2) and metallothionein-3 (MT-3) (UniProt:P25713-1) were purchased from Genscript (Piscataway, NJ, USA) and inserted into the pTYB21 vector (New England Biolabs, UK). Prepared plasmid transformed into BL21(DE3)pLysS E. coli cells. Protein production and purification was conducted as previously stated [36]. The obtained recombinant protein MT-1 used in the MALDI-MS experiments had seven bound Zn(II) ions. For LA-ICP-MS experiments were prepared MT-1 with seven bound Cd(II) ions and MT-3 with seven bound Zn(II) ions. 6 Plasma sample preparation Whole blood was collected from a healthy volunteer and then the whole blood was centrifuged for 10 min at 2000 rcf and the plasma was further centrifuged for 30 min at 22000 rcf. The plasma was diluted 50× with Tris-HCl buffer (20 mM, pH 8.5) and spiked with MT-1 to its final concentration of 5 μM. All subjects gave their informed consent for inclusion, before participating in the study. The study was conducted in accordance with the Declaration of Helsinki and the protocol was approved by the Ethics Committee of Masaryk University. MALDI-TOF-MS MIP/NIP were analysed using MALDI-TOF-MS (ultrafleXtreme instrument, Bruker Daltonik GmbH, Bremen Germany) equipped with a laser (operating at wavelength of 355 nm with an accelerating voltage of 25 kV, a maximum energy of 43.2 μJ, and a repetition rate of 2000 Hz) in linear positive ion mode for data acquisition. Three different organic matrix solutions were tested, namely α-cyano-4-hydroxycinnamic acid, sinapinic acid and 2,5dihydroxybenzoic acid (DHB) (Bruker Daltonik, Bremen, Germany), with DHB diluted in 0,1% trifluoroacetic acid (Sigma-Aldrich) being considered the optimal solution, since less background was produced in the final spectrum [18]. Matrix (0.5 µL) was applied on the prepared MIP and/or NIP polymerized layer (as previously described in section 2.2) and dried under atmospheric pressure and ambient temperature (25 °C). The laser frequency was set to 1000 Hz and laser energy was optimized prior to each measurement. Calibration was done externally using a protein standard mixture I and II (Bruker Daltonics, Bremen, Germany) in the range of m/z 1–90 kDa. A total of 500 spectra were summed for each spot using the Random Walk raster pattern, with no evaluation criteria and were analysed with the Flex Analysis software (Version 3.4). 7 Fluorescence spectrometry Fluorescence spectrometric measurements were performed using Infinite M200 fluorescence microplate reader (Tecan, Männedorf, CH). Polymerization mixture (50 µL) was deposited on the bottom of the well of Corning® 96 Well Clear Flat Bottom UV-Transparent Microplate (Corning, NY, USA). Fluorescence emission of lysozyme was recorded at λex = 280 nm and λem = 330 nm with gain of the detector set to 100. LA-ICP-MS The analysis of MIP was performed by LA-ICP-MS setup that consists of LA system UP213 (NewWave Research, USA) emitting laser radiation with a wavelength of 213 nm with a pulse width of 4.2 ns. The ablated material was carried out from an ablation cell by a flow of a He (1.0 l/min) into ICP-MS Agilent 7500CE (Agilent Technologies, Japan) with quadrupole analyzer. The MIP and NIP were ablated with following ablation parameters: laser beam diameter of 110 μm, the repetition rate of 10 Hz; laser beam fluence of 6 J/cm2, the scan speed of 400 μm/s and distance between individual lines of 100 μm. The analytes MT-1 and MT-3 were monitored by measuring of isotope 111Cd and 66Zn, respectively. Results and discussion Optimization of MIPs preparation To address limitations of protein imprinting, several strategies have been investigated including metal ion-coordination polymerization, protein epitope approach, and surface imprinting [22, 25, 37]. The latter approach utilizes polydopamine (PDA), one of the most favourable polymers considering its green chemistry status and facile preparation. Dopamine 8 (DA), a functional monomer, can form a thin, self-polymerizing film on a wide variety of materials in a weak alkaline environment (pH > 8) [38]. It has been shown that PDA forms thin films by the spontaneous polymerization in the presence of oxygen; however some other polymerization methods involving radicals formation have been developed [39]. DA, commonly involved in human body as a neurotransmitter, is also a small-molecule mimicking the adhesive proteins. Its multifunctional groups and properties of hydrophilicity and biocompatibility make it suitable for imprinting of proteins. It can be self-polymerized under mild conditions (room temperature, pH 8.0) resulting in formation of an adherent polydopamine film. For example, approach for imprinting proteins using PDA coating of Fe3O4 nanoparticles has been reported [40]. Xia et al. suggested an approach for protein recognition and separation using PDA-coated molecularly imprinted silica nanoparticles [41]. Therefore, it is believed that polydopamine MIPs are expedient and appropriate materials applicable in the identification of proteins. The simple oxidative polymerization was employed in this study. For non-covalent imprinting, the optimal ratio of template to functional monomer (T/M) has to be achieved empirically [42]. Therefore, the concentration of monomer (dopamine) was tested in concentrations of 16, 32, 65, and 130 mM (data not shown). The functionality of the imprinted polymer was initially tested utilizing lysozyme as a template. The globular glycoprotein lysozyme (Lys) plays and important role in living organisms. Considering its excellent antibacterial property, Lys is widely used in medical and food industry. Thus, the development of an effective purification method for Lys is broadly valuable [43]. Based on the intrinsic fluorescence of Lys, the efficiency of the polymeric layer preparation was evaluated. According to the fluorescence spectrometry measurements, the dopamine concentration of 16 mM was chosen as the most appropriate due to the highest binding yield. 15 Figures Figure 1 Overall workflow of molecularly imprinted polymer (MIP) formation, sampling and MALDIMS detection of MT-1. 16 Figure 2 LA-ICP-MS quantification of 66Zn of different MT-1 concentrations in the sample extracted by MIP (red) and NIP (grey). 66Zn quantification in MIP after template removal is shown in blue. 17 Figure 3 LA-ICP-MS analyses of MIP and NIP using the MT-1 (Cd) and MT-3 (Zn) templates. (A) Sample containing MT-3(Zn) was applied to MIP/NIP created with template MT-1(Cd). (B) Sample containing MT-1(Cd) was applied to MIP/NIP created with template MT-3(Zn), (C) Sample containing MT-3(Zn) and MT-1(Cd) was applied to MIP/NIP created with template MT-1(Cd). 18 Figure 4 Stacked overlay of MALDI-TOF-MS data using MT-MIP purification of the plasma spiked with 5 μM MT-1 (red), in comparison with NIP purification (blue), MT-1 peak (m/z 6071.5) is marked with (*). 19 References [1] P. Coyle, J.C. Philcox, L.C. Carey, A.M. Rofe, Metallothionein: The multipurpose protein, Cell. Mol. Life Sci. 59(4) (2002) 627-647. [2] M.A. Dunn, T.L. Blalock, R.J. Cousins, Metallothionein, Proc. Soc. Exp. Biol. Med. 185(2) (1987) 107-119. [3] D.H. Hamer, Metallothionein, Annu. Rev. Biochem. 55 (1986) 913-951. [4] A.T. Miles, G.M. Hawksworth, J.H. Beattie, V. Rodilla, Induction, regulation, degradation, and biological significance of mammalian metallothioneins, Crit. Rev. Biochem. Mol. Biol. 35(1) (2000) 35-70. [5] J.H. Beattie, A.M. Wood, P. Trayhurn, B. Jasani, A. Vincent, G. McCormack, A.K. West, Metallothionein is expressed in adipocytes of brown fat and is induced by catecholamines and zinc, Am. J. Physiol.-Regul. Integr. Comp. Physiol. 278(4) (2000) R1082-R1089. [6] W. Maret, The function of zinc metallothionein: A link between cellular zinc and redox state, J. Nutr. 130(5) (2000) 1455S-1458S. [7] B. Ruttkay-Nedecky, L. Nejdl, J. Gumulec, O. Zitka, M. Masarik, T. Eckschlager, M. Stiborova, V. Adam, R. Kizek, The Role of Metallothionein in Oxidative Stress, Int. J. Mol. Sci. 14(3) (2013) 6044-6066. [8] M. Capdevila, R. Bofill, O. Palacios, S. Atrian, State-of-the-art of metallothioneins at the beginning of the 21st century, Coord. Chem. Rev. 256(1-2) (2012) 46-62. [9] T. Eckschlager, V. Adam, J. Hrabeta, K. Figova, R. Kizek, Metallothioneins and Cancer, Curr. Protein Pept. Sci. 10(4) (2009) 360-375. [10] J. Gumulec, M. Raudenska, V. Adam, R. Kizek, M. Masarik, Metallothionein - Immunohistochemical Cancer Biomarker: A Meta-Analysis, PLoS One 9(1) (2014) 1-14. [11] C. Ferrario, P. Lavagni, M. Gariboldi, C. Miranda, M. Losa, L. Cleris, F. Formelli, S. Pilotti, M.A. Pierotti, A. Greco, Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma, Lab. Invest. 88(5) (2008) 474-481. [12] J. Fu, H.J. Lv, H.X. Guan, X.Y. Ma, M.J. Ji, N.Y. He, B.Y. Shi, P. Hou, Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway, BMC Cancer 13 (2013) 1-13. [13] M. Kanda, S. Nomoto, Y. Okamura, Y. Nishikawa, H. Sugimoto, N. Kanazumi, S. Takeda, A. Nakao, Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis, Int. J. Oncol. 35(3) (2009) 477-483. [14] M. Ryvolova, S. Krizkova, V. Adam, M. Beklova, L. Trnkova, J. Hubalek, R. Kizek, Analytical Methods for Metallothionein Detection, Curr. Anal. Chem. 7(3) (2011) 243-261. 20 [15] V. Adam, I. Fabrik, T. Eckschlager, M. Stiborova, L. Trnkova, R. Kizek, Vertebrate metallothioneins as target molecules for analytical techniques, Trac-Trends Anal. Chem. 29(5) (2010) 409-418. [16] A. Houessinon, C. Franois, C. Sauzay, C. Louandre, G. Mongelard, C. Godin, S. Bodeau, S. Takahashi, Z. Saidak, L. Gutierrez, J.M. Regimbeau, N. Barget, J.C. Barbare, N. Ganne, B. Chauffert, R. Coriat, A. Galmiche, Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib, Mol. Cancer 15 (2016) 110. [17] L. Nejdl, H.V. Nguyen, L. Richtera, S. Krizkova, R. Guran, M. Masarik, D. Hynek, Z. Heger, K. Lundberg, K. Erikson, V. Adam, R. Kizek, Label-free bead-based metallothionein electrochemical immunosensor, Electrophoresis 36(16) (2015) 1894-1904. [18] M.A.M. Rodrigo, J. Molina-Lopez, A.M.J. Jimenez, E.P. Del Pozo, P. Adam, T. Eckschlager, O. Zitka, L. Richtera, V. Adam, The Application of Curve Fitting on the Voltammograms of Various Isoforms of Metallothioneins-Metal Complexes, Int. J. Mol. Sci. 18(3) (2017) 1-11. [19] K. Coufalikova, I. Benesova, T. Vaculovic, V. Kanicky, J. Preisler, LC coupled to ESI, MALDI and ICP MS - A multiple hyphenation for metalloproteomic studies, Anal. Chim. Acta 968 (2017) 58-65. [20] J.B. Shabb, W.W. Muhonen, A.A. Mehus, Quantitation of Human Metallothionein Isoforms in Cells, Tissues, and Cerebrospinal Fluid by Mass Spectrometry, in: A.K. Shukla (Ed.), Proteomics in Biology, Pt B2017, pp. 413-431. [21] G. Wulff, Molecular Imprinting in Cross-Linked Materials with the Aid of Molecular Templates - A Way towards Artificial Antibodies, Angew. Chem.-Int. Edit. Engl. 34(17) (1995) 1812-1832. [22] L.X. Chen, S.F. Xu, J.H. Li, Recent advances in molecular imprinting technology: current status, challenges and highlighted applications, Chem. Soc. Rev. 40(5) (2011) 29222942. [23] G. Vasapollo, R. Del Sole, L. Mergola, M.R. Lazzoi, A. Scardino, S. Scorrano, G. Mele, Molecularly Imprinted Polymers: Present and Future Prospective, Int. J. Mol. Sci. 12(9) (2011) 5908-5945. [24] K. Smolinska-Kempisty, A. Guerreiro, F. Canfarotta, C. Caceres, M.J. Whitcombe, S. Piletsky, A comparison of the performance of molecularly imprinted polymer nanoparticles for small molecule targets and antibodies in the ELISA format, Sci. Rep. 6 (2016) 1-7. [25] A. Bossi, F. Bonini, A.P.F. Turner, S.A. Piletsky, Molecularly imprinted polymers for the recognition of proteins: The state of the art, Biosens. Bioelectron. 22(6) (2007) 11311137. [26] M. Bertolla, L. Cenci, A. Anesi, E. Ambrosi, F. Tagliaro, L. Vanzetti, G. Guella, A.M. Bossi, Solvent-Responsive Molecularly Imprinted Nanogels for Targeted Protein Analysis in MALDI-TOF Mass Spectrometry, ACS Appl. Mater. Interfaces 9(8) (2017) 6908-6915. 21 [27] Y. Chen, D.J. Li, Z.J. Bie, X.P. He, Z. Liu, Coupling of Phosphate-Imprinted Mesoporous Silica Nanoparticles-Based Selective Enrichment with Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry for Highly Efficient Analysis of Protein Phosphorylation, Anal. Chem. 88(2) (2016) 1447-1454. [28] A.N. Tang, L.P. Duan, M.J. Liu, X.C. Dong, An epitope imprinted polymer with affinity for kininogen fragments prepared by metal coordination interaction for cancer biomarker analysis, J. Mat. Chem. B 4(46) (2016) 7464-7471. [29] R.M. Caprioli, T.B. Farmer, J. Gile, Molecular imaging of biological samples: Localization of peptides and proteins using MALDI-TOF MS, Anal. Chem. 69(23) (1997) 4751-4760. [30] W.T. Jia, H.X. Wu, H.J. Lui, N. Li, Y. Zhang, R.F. Cai, P.Y. Yang, Rapid and automatic on-plate desalting protocol for MALD-MS: Using imprinted hydrophobic polymer template, Proteomics 7(15) (2007) 2497-2506. [31] A. Mathur, S. Blais, C.M.V. Goparaju, T. Neubert, H. Pass, K. Levon, Development of a Biosensor for Detection of Pleural Mesothelioma Cancer Biomarker Using Surface Imprinting, PLoS One 8(3) (2013) 1-8. [32] F. Sineriz, Y. Ikeda, E. Petit, L. Bultel, K. Haupt, J. Kovensky, D. Papy-Garcia, Toward an alternative for specific recognition of sulfated sugars. Preparation of highly specific molecular imprinted polymers, Tetrahedron 63(8) (2007) 1857-1862. [33] W. Wan, Q. Han, X.Q. Zhang, Y.M. Xie, J.P. Sun, M.Y. Ding, Selective enrichment of proteins for MALDI-TOF MS analysis based on molecular imprinting, Chem. Commun. 51(17) (2015) 3541-3544. [34] M. Zhang, X.H. Zhang, X.W. He, L.X. Chen, Y.K. Zhang, A self-assembled polydopamine film on the surface of magnetic nanoparticles for specific capture of protein, Nanoscale 4(10) (2012) 3141-3147. [35] R.X. Gao, L.L. Zhang, Y. Hao, X.H. Cui, Y.H. Tang, Specific removal of protein using protein imprinted polydopamine shells on modified amino-functionalized magnetic nanoparticles, RSC Adv. 4(110) (2014) 64514-64524. [36] N.E. Wezynfeld, E. Stefaniak, K. Stachucy, A. Drozd, D. Plonka, S.C. Drew, A. Krezel, W. Bal, Resistance of Cu(A beta 4-16) to Copper Capture by Metallothionein-3 Supports a Function for the A beta 4-42 Peptide as a Synaptic Cu-II Scavenger, Angew. Chem.-Int. Edit. 55(29) (2016) 8235-8238. [37] K. Eersels, P. Lieberzeit, P. Wagner, A Review on Synthetic Receptors for Bioparticle Detection Created by SurfaceSensors 1(10) (2016) 1171-1187. [38] Y.L. Liu, K.L. Ai, L.H. Lu, Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields, Chem. Rev. 114(9) (2014) 5057-5115. [39] T.P. Chen, T.C. Liu, T.L. Su, J.F. Liang, Self-Polymerization of Dopamine in Acidic Environments without Oxygen, Langmuir 33(23) (2017) 5863-5871. 22 [40] W.H. Zhou, C.H. Lu, X.C. Guo, F.R. Chen, H.H. Yang, X.R. Wang, Mussel-inspired molecularly imprinted polymer coating superparamagnetic nanoparticles for protein recognition, J. Mater. Chem. 20(5) (2010) 880-883. [41] Z.W. Xia, Z.A. Lin, Y. Xiao, L. Wang, J.N. Zheng, H.H. Yang, G.N. Chen, Facile synthesis of polydopamine-coated molecularly imprinted silica nanoparticles for protein recognition and separation, Biosens. Bioelectron. 47 (2013) 120-126. [42] D.A. Spivak, Optimization, evaluation, and characterization of molecularly imprinted polymers, Adv. Drug Deliv. Rev. 57(12) (2005) 1779-1794. [43] K.J. Xu, Y.Z. Wang, X.X. Wei, J. Chen, P.L. Xu, Y.G. Zhou, Preparation of magnetic molecularly imprinted polymers based on a deep eutectic solvent as the functional monomer for specific recognition of lysozyme, Microchimica Acta 185(2) (2018) 146-154. [44] G.H. Yao, R.P. Liang, C.F. Huang, Y. Wang, J.D. Qiu, Surface Plasmon Resonance Sensor Based on Magnetic Molecularly Imprinted Polymers Amplification for Pesticide Recognition, Anal. Chem. 85(24) (2013) 11944-11951. [45] F. Lan, S.H. Ma, Q. Yang, L.Q. Xie, Y. Wu, Z.W. Gu, Polydopamine-based superparamagnetic molecularly imprinted polymer nanospheres for efficient protein recognition, Colloid Surf. B-Biointerfaces 123 (2014) 213-218. [46] Y.L. Jeyachandran, E. Mielezarski, B. Rai, J.A. Mielczarski, Quantitative and Qualitative Evaluation of Adsorption/Desorption of Bovine Serum Albumin on Hydrophilic and Hydrophobic Surfaces, Langmuir 25(19) (2009) 11614-11620. [47] H.M. Chen, C.H. Deng, X.M. Zhang, Synthesis of Fe3O4@SiO2@PMMA Core-ShellShell Magnetic Microspheres for Highly Efficient Enrichment of Peptides and Proteins for MALDI-ToF MS Analysis, Angew. Chem.-Int. Edit. 49(3) (2010) 607-611. [48] S. Krizkova, M. Ryvolova, J. Gumulec, M. Masarik, V. Adam, P. Majzlik, J. Hubalek, I. Provaznik, R. Kizek, Electrophoretic fingerprint metallothionein analysis as a potential prostate cancer biomarker, Electrophoresis 32(15) (2011) 1952-1961. [49] A.S. Benk, C. Roesli, Label-free quantification using MALDI mass spectrometry: considerations and perspectives, Anal. Bioanal. Chem. 404(4) (2012) 1039-1056. [50] A. Krezel, W. Maret, The Functions of Metamorphic Metallothioneins in Zinc and Copper Metabolism, Int. J. Mol. Sci. 18(6) (2017).